✦ LIBER ✦

[Cancer Drug Discovery and Development] Nuclear Signaling Pathways and Targeting Transcription in Cancer || The Potential of Targeting Splicing for Cancer Therapy

✍ Scribed by Kumar, Rakesh

Book ID: 120929446
Publisher: Springer New York
Year: 2013
Weight: 606 KB
Category: Article
ISBN: 1461480396
DOI: 10.1007/978-1-4614-8039-6_13

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Cancer Drug Discovery and Development]

[Cancer Drug Discovery and Development] Nuclear Signaling Pathways and Targeting Transcription in Cancer || Nuclear Factors Linking Cancer and Inflammation

✍ Kumar, Rakesh 📂 Article 📅 2013 🏛 Springer New York ⚖ 930 KB

[Cancer Drug Discovery and Development]

[Cancer Drug Discovery and Development] Nuclear Signaling Pathways and Targeting Transcription in Cancer || Epigenetic Mechanisms of Cancer Metastasis

✍ Kumar, Rakesh 📂 Article 📅 2013 🏛 Springer New York ⚖ 484 KB

[Cancer Drug Discovery and Development]

[Cancer Drug Discovery and Development] Nuclear Signaling Pathways and Targeting Transcription in Cancer || Receptor Tyrosine Kinases in the Nucleus: Nuclear Functions and Therapeutic Implications in Cancers

✍ Kumar, Rakesh 📂 Article 📅 2013 🏛 Springer New York ⚖ 954 KB

[Cancer Drug Discovery and Development]

[Cancer Drug Discovery and Development] Nuclear Signaling Pathways and Targeting Transcription in Cancer || Nucleolar Signaling Determines Cell Fate: The RP-Mdm2-p53 Axis Fine-Tunes Cellular Homeostasis

✍ Kumar, Rakesh 📂 Article 📅 2013 🏛 Springer New York ⚖ 488 KB

Functional Proteomics of Breast Cancer f

Functional Proteomics of Breast Cancer for Signal Pathway Profiling and Target Discovery

✍ Hubert Hondermarck; Laurent Dollé; Ikram El Yazidi-Belkoura; Anne-Sophie Vercout 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 704 KB

The discovery and validation of new drug

The discovery and validation of new drug targets in cancer

✍ Sara A Courtneidge; Greg D Plowman 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 672 KB

Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the